These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23825307)

  • 1. Decisional outcomes of maternal disclosure of BRCA1/2 genetic test results to children.
    Tercyak KP; Mays D; DeMarco TA; Peshkin BN; Valdimarsdottir HB; Schneider KA; Garber JE; Patenaude AF
    Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1260-6. PubMed ID: 23825307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children.
    Tercyak KP; Peshkin BN; Demarco TA; Patenaude AF; Schneider KA; Garber JE; Valdimarsdottir HB; Schwartz MD
    Genet Test; 2007; 11(3):249-55. PubMed ID: 17949286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parenting through genetic uncertainty: themes in the disclosure of breast cancer risk information to children.
    Sharff ME; DeMarco TA; Mays D; Peshkin BN; Valdimarsdottir HB; Garber JE; Schneider KA; Patenaude AF; Tercyak KP
    Genet Test Mol Biomarkers; 2012 May; 16(5):376-82. PubMed ID: 22085394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distress and the parenting dynamic among BRCA1/2 tested mothers and their partners.
    Mays D; DeMarco TA; Luta G; Peshkin BN; Patenaude AF; Schneider KA; Garber JE; Tercyak KP
    Health Psychol; 2014 Aug; 33(8):765-73. PubMed ID: 23795707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of parenting relationship quality in communicating about maternal BRCA1/2 genetic test results with children.
    DeMarco TA; Peshkin BN; Valdimarsdottir HB; Patenaude AF; Schneider KA; Tercyak KP
    J Genet Couns; 2008 Jun; 17(3):283-7. PubMed ID: 18288593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An investigation of the disclosure process and support needs of BRCA1 and BRCA2 carriers.
    Segal J; Esplen MJ; Toner B; Baedorf S; Narod S; Butler K
    Am J Med Genet A; 2004 Mar; 125A(3):267-72. PubMed ID: 14994235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations.
    Finlay E; Stopfer JE; Burlingame E; Evans KG; Nathanson KL; Weber BL; Armstrong K; Rebbeck TR; Domchek SM
    Genet Test; 2008 Mar; 12(1):81-91. PubMed ID: 18373407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The big reveal: Family disclosure patterns of BRCA genetic test results among young Black women with invasive breast cancer.
    Conley CC; Ketcher D; Reblin M; Kasting ML; Cragun D; Kim J; Ashing KT; Knott CL; Hughes-Halbert C; Pal T; Vadaparampil ST
    J Genet Couns; 2020 Jun; 29(3):410-422. PubMed ID: 31912597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation and outcomes of telephone disclosure of clinical BRCA1/2 test results.
    Patrick-Miller L; Egleston BL; Daly M; Stevens E; Fetzer D; Forman A; Bealin L; Rybak C; Peterson C; Corbman M; Bradbury AR
    Patient Educ Couns; 2013 Dec; 93(3):413-9. PubMed ID: 24075727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the development of a decision support intervention for mothers undergoing BRCA1/2 cancer genetic testing regarding communicating test results to their children.
    Peshkin BN; Demarco TA; Tercyak KP
    Fam Cancer; 2010 Mar; 9(1):89-97. PubMed ID: 19609726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Talking to children about maternal BRCA1/2 genetic test results: a qualitative study of parental perceptions and advice.
    Farkas Patenaude A; DeMarco TA; Peshkin BN; Valdimarsdottir H; Garber JE; Schneider KA; Hewitt L; Hamilton J; Tercyak KP
    J Genet Couns; 2013 Jun; 22(3):303-14. PubMed ID: 23093334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How often do BRCA mutation carriers tell their young children of the family's risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults.
    Bradbury AR; Dignam JJ; Ibe CN; Auh SL; Hlubocky FJ; Cummings SA; White M; Olopade OI; Daugherty CK
    J Clin Oncol; 2007 Aug; 25(24):3705-11. PubMed ID: 17704419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review.
    Krassuski L; Vennedey V; Stock S; Kautz-Freimuth S
    BMC Med Inform Decis Mak; 2019 Aug; 19(1):154. PubMed ID: 31370837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal perceptions of BRCA genetic counseling communication processes about disclosing cancer risk information to children and adult relatives.
    Hamilton JG; Peshkin BN; Mays D; DeMarco TA; Patenaude AF; Tercyak KP
    Psychooncology; 2018 Jul; 27(7):1825-1832. PubMed ID: 29645321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which factors predict proposal and uptake of psychological counselling after BRCA1/2 test result disclosure?
    Maheu C; Bouhnik AD; Nogues C; Mouret-Fourme E; Stoppa-Lyonnet D; Lasset C; Berthet P; Fricker JP; Caron O; Luporsi E; Gladieff L; Julian-Reynier C
    Psychooncology; 2014 Apr; 23(4):420-7. PubMed ID: 24127257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families.
    Flores KG; Steffen LE; McLouth CJ; Vicuña BE; Gammon A; Kohlmann W; Vigil L; Dayao ZR; Royce ME; Kinney AY
    J Genet Couns; 2017 Jun; 26(3):480-490. PubMed ID: 27496122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parental Decision Making Regarding the Disclosure or Nondisclosure of a Mutation-Positive BRCA1/2 Test Result to Minors.
    Seenandan-Sookdeo KA; Hack TF; Lobchuk M; Murphy L; Marles S
    Oncol Nurs Forum; 2016 May; 43(3):330-41. PubMed ID: 27105194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
    Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
    JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can we test for hereditary cancer at 18 years when we start surveillance at 25? Patient reported outcomes.
    Sie AS; Prins JB; Spruijt L; Kets CM; Hoogerbrugge N
    Fam Cancer; 2013 Dec; 12(4):675-82. PubMed ID: 23604858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parental disclosure of positive
    Troïan J; Apostolidis T; Touzani R; Mouret-Fourme E; Stoppa-Lyonnet D; Lasset C; Berthet P; Julian-Reynier C; Mancini J; Noguès C; Bouhnik AD
    Psychol Health Med; 2020 Jul; 25(6):756-766. PubMed ID: 31505944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.